Astec Lifesciences gets nod to raise Rs 50 crore via NCDs

31 Jan 2023 Evaluate

Astec Lifesciences’ board has approved the proposal to raise funds through issuance of Non-Convertible Debentures (NCD) for expansion and development of business operations of the Company and meeting the short term and long-term financial requirements of the Company, including but not limited to, expenditure proposed to be incurred for improving the facilities being provided in its set-up and / or meeting the working capital requirements, for an amount upto Rs 50 crore. The Board of Directors of the Company, at its Meeting held on January 30, 2023 has approved the same.

Astec Lifesciences manufactures a wide range of agrochemicals and pharmaceutical intermediates.

Astec Lifesciences Share Price

615.55 -8.75 (-1.40%)
24-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 630.45
PI Industries 3111.35
Bayer CropScience 4714.80
Sharda Cropchem 1163.85
Sumitomo Chemical 405.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×